Nurix Therapeutics Statistics
Total Valuation
NRIX has a market cap or net worth of $717.09 million. The enterprise value is $283.24 million.
Important Dates
The next estimated earnings date is Thursday, October 9, 2025, after market close.
| Earnings Date | Oct 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NRIX has 76.45 million shares outstanding. The number of shares has increased by 40.74% in one year.
| Current Share Class | 76.45M |
| Shares Outstanding | 76.45M |
| Shares Change (YoY) | +40.74% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 96.24% |
| Float | 61.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.45 |
| Forward PS | 10.47 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 1.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.82, with a Debt / Equity ratio of 0.12.
| Current Ratio | 6.82 |
| Quick Ratio | 6.70 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -50.67% and return on invested capital (ROIC) is -32.04%.
| Return on Equity (ROE) | -50.67% |
| Return on Assets (ROA) | -26.13% |
| Return on Invested Capital (ROIC) | -32.04% |
| Return on Capital Employed (ROCE) | -44.67% |
| Revenue Per Employee | $309,024 |
| Profits Per Employee | -$724,895 |
| Employee Count | 286 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRIX has paid $850,000 in taxes.
| Income Tax | 850,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.31% in the last 52 weeks. The beta is 2.34, so NRIX's price volatility has been higher than the market average.
| Beta (5Y) | 2.34 |
| 52-Week Price Change | -57.31% |
| 50-Day Moving Average | 9.73 |
| 200-Day Moving Average | 12.92 |
| Relative Strength Index (RSI) | 52.39 |
| Average Volume (20 Days) | 1,157,060 |
Short Selling Information
The latest short interest is 13.05 million, so 17.06% of the outstanding shares have been sold short.
| Short Interest | 13.05M |
| Short Previous Month | 12.81M |
| Short % of Shares Out | 17.06% |
| Short % of Float | 21.23% |
| Short Ratio (days to cover) | 16.01 |
Income Statement
In the last 12 months, NRIX had revenue of $88.38 million and -$207.32 million in losses. Loss per share was -$2.60.
| Revenue | 88.38M |
| Gross Profit | -182.08M |
| Operating Income | -230.45M |
| Pretax Income | -206.47M |
| Net Income | -207.32M |
| EBITDA | -222.22M |
| EBIT | -230.45M |
| Loss Per Share | -$2.60 |
Full Income StatementBalance Sheet
The company has $485.78 million in cash and $51.93 million in debt, giving a net cash position of $433.85 million or $5.68 per share.
| Cash & Cash Equivalents | 485.78M |
| Total Debt | 51.93M |
| Net Cash | 433.85M |
| Net Cash Per Share | $5.68 |
| Equity (Book Value) | 447.60M |
| Book Value Per Share | 5.86 |
| Working Capital | 439.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$215.18 million and capital expenditures -$10.61 million, giving a free cash flow of -$225.79 million.
| Operating Cash Flow | -215.18M |
| Capital Expenditures | -10.61M |
| Free Cash Flow | -225.79M |
| FCF Per Share | -$2.95 |
Full Cash Flow StatementMargins
Gross margin is -206.02%, with operating and profit margins of -260.75% and -234.58%.
| Gross Margin | -206.02% |
| Operating Margin | -260.75% |
| Pretax Margin | -233.61% |
| Profit Margin | -234.58% |
| EBITDA Margin | -251.43% |
| EBIT Margin | -260.75% |
| FCF Margin | n/a |
Dividends & Yields
NRIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.74% |
| Shareholder Yield | -40.74% |
| Earnings Yield | -28.91% |
| FCF Yield | -31.49% |
Analyst Forecast
The average price target for NRIX is $29.07, which is 209.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $29.07 |
| Price Target Difference | 209.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 44.40% |
| EPS Growth Forecast (5Y) | -9.50% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRIX has an Altman Z-Score of 3.21 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.21 |
| Piotroski F-Score | 3 |
